1/25
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
liquid anesthetics
liquid anesthetic is vaporized and delivered by carrier gas to pt through inspiratory tubing
diffusion of anesthetic gas
gas anesthetic crosses alveoli to the bloodstream
rate of diffusion is controlled by concentration gradient
during induction
concentration of gas in alveoli is high
concentration of gas in bloodstream is low
results in rapid diffusion of anesthetic gas
depth/maintenance of anesthesia
depth is determined by concentration of anesthetic in the brain
anesthesia is maintained by insuring concentration of anesthetic in alveoli, blood and brain is maintained
recovery
when concentration of gas in blood is less than brain anesthetic will diffuse from brain to blood to alveoli
as levels in brain decrease, pt will regain consciousness
after vaporizer is turned off
animals should breathe 100% O2 for up to 5 min
precision vaporizers
deliver inhalants as %
are VOC, bc they sit outside the breathing circuit
VOC
vaporizer out of circuit
create high resistance to gas flow so they sit out of the breathing circuit
nitrous oxide
N2O
not common in vet med
wide margin of safety
provides analgesia, muscle relaxation, and sedation
blue cylinder
nitrous oxide- risk of hypoxia
effects of inhalant anesthetics
physical properties of inhalant anesthetics
vapor pressure
solubility
MAC
vapor pressure
measure tendency of anesthetic to go from liquid to gas
high vapor pressure = wants to be a gas
need to be used with VOC
solubility
solubility coefficient measures to solubility of an anesthetic gas
provides info on speed of induction, depth change and recovery
low solubility = fast gas
move rapidly to the brain
high solubility inhalants
low solubility inhalants
MAC
halothane
high vapor pressure
medium solubility
medium MAC
halothane- adverse effects
halothane — effects
isoflurane
higher MAC
high vapor pressure
low solubility
isoflurane- effects
sevoflurane
lowest solubility
highest MAC
high vapor pressure
sevoflurane- effects
desflurane
malignant hyperthermia